Taro Pharmaceutical Industries
Topical Pharmaceutical, Dermatological, and Cosmetic Products
Startup Acquired Health Tech & Life Sciences Est. 1959
Total Raised
Undisclosed
Acquired
Last Round
Undisclosed
1 rounds
Team
6
500+ employees
Confidence
88/100
News
41
articles
Patents
1
About
Taro Pharmaceutical Industries is a research-based international pharmaceutical company manufacturing topical dermatological products and developing a line of solid drugs in cardiology and neurology. Taro synthesizes the active ingredients used in many of its key products. This vertical integration gives Taro control over the manufacturing and quality-control process from the active ingredients to the finished product and provides the company with a competitive advantage in the availability of quality raw materials, the reliability of supply, and the cost of active pharmaceutical ingredients.
Classification
Sector
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Core Technology
Materials & SubstancesRaw Materials
Target Customer
Healthcare & Life SciencesLife SciencesPharmaceuticalsHealthcarePatients
Business Model
B2B
Tags
pharmaceuticalsmanufacturinghealthcare-providerstopical-treatmentcardiovascularoral-drugspediatricsdrug-discoveryhospitalsdermatologyanti-inflammatorytreatments
Funding & Events
Mar 2012
Exit Undisclosed
Jun 2024
Exit Undisclosed
Jun 2024
Exit $348M
News (41)
Jun 23, 2024 · www.prnewswire.com
growth-positive
Sun Pharma Completes Taro Merger
Acquisition
May 23, 2024 · www.prnewswire.com
growth-positive
Taro Shareholders Approve Merger with Sun Pharma
Acquired-by
May 23, 2024 · finance.yahoo.com
growth-positive
Taro Shareholders Approve Merger with Sun Pharma
Acquired-by
May 20, 2024 · www.businesswire.com
Taro Provides Results for Year Ended March 31, 2024
May 8, 2024 · www.businesswire.com
Leading Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Taro Shareholders Vote "FOR" Taro Sun Pharma Merger
Apr 14, 2024 · www.businesswire.com
Taro Announces Extraordinary General Meeting and Ordinary Class Meeting of Shareholders for Approval of Merger with Sun Pharmaceutical Industries Ltd.
Mar 7, 2024 · finance.yahoo.com
growth-positive
Chemical Linked to Cancer Found in Acne Creams Including Proactiv, Clearasil
Customers
Jan 30, 2024 · www.prnewswire.com
Growth-Negative
Krensavage Asset Management Remains Opposed to Sun's Predatory Bid for Taro
AcquisitionInvestment
Jan 25, 2024 · www.businesswire.com
Taro Provides Results for December 31, 2023
Jan 17, 2024 · sg.finance.yahoo.com
growth-positive
India's Sun Pharma to buy remaining stake in Israeli unit Taro for about $348 million
Acquisition
Jan 17, 2024 · www.prnewswire.com
growth-positive
Taro Announces Merger Agreement with Sun Pharma
Acquisition
Jan 17, 2024 · finance.yahoo.com
growth-positive
Taro Announces Merger Agreement with Sun Pharma
AcquisitionManagement Changes
Dec 29, 2023 · finance.yahoo.com
Growth-Positive
Amicus (FOLD) Banks on Galafold, Overdependence a Concern
CustomersInvestment
Dec 28, 2023 · finance.yahoo.com
growth-negative
Iovance (IOVA) Falls After Clinical Update on Lung Cancer Drug
Management Changes
Dec 26, 2023 · finance.yahoo.com
growth-positive
Cidara (CDTX) Up on EC Nod for Rezzayo in Invasive Candidiasis
CustomersPartnersInvestment
Dec 26, 2023 · finance.yahoo.com
Growth-Positive
Senti Bio (SNTI) Rises as FDA Clears IND for Cancer Candidate
InvestmentPartners
Dec 22, 2023 · finance.yahoo.com
growth-negative
Sanofi (SNY) Discontinues Tusamitamab Ravtansine Cancer Program
Management Changes
Oct 26, 2023 · www.businesswire.com
Taro Provides Results for September 30, 2023
Jul 27, 2023 · www.businesswire.com
growth-positive
Taro Provides Results for the Quarter Ended June 30, 2023
Customers
Jul 19, 2023 · www.prnewswire.com
growth-negative
Krensavage Asset Management Opposes Sun's Lowball Bid for Taro
Acquisition
+ 21 more articles
Details
Product Stage
Released
Employees
500+
Exact Count
1344
District
North District
Founded
1959
Registrar
520022906
Crunchbase
taro-pharmaceuticals
Locations
HaKitor Street 14, Haifa, Israel
3 Skyline Drive, Hawthorne, NY, USA
130 East Dr, Brampton, ON, Canada
Links
Website
LinkedIn
Admin
Last Update
Feb 26, 2025
Verified by
Natalia Golczar
Missing
video or image, funding rounds, markets, not claimed
Team (6)
Uday Baldota
CEO
Michael Perfetto
CCO
Avi Avramoff
Global VP R&D
Michele Visosky
Group VP Human Resources
Barbara Pimentel
VP Sales & Marketing
Andreas Wegner
VP, Head of Manufacturing